Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

HHS - 769 - Advisory Committee on Infant Mortality - Authorized by Law


Committee NameAdvisory Committee on Infant MortalityAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number769
Original Establishment Date6/28/1991Committee StatusChartered
Actual Termination Date Committee URL
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*21
Current Charter Date9/30/2019Designated Fed Officer Position Title*Deputy Director, DHSPS / Principal Staff and DFO, Secretary's Adv Com. on Infant Mortality & HRSA Assoc Adm
Date Of Renewal Charter9/30/2021Designated Federal Officer PrefixDr.
Projected Termination Date Designated Federal Officer First Name*David
Exempt From Renewal*NoDesignated Federal Officer Middle NameS.
Specific Termination AuthorityDesignated Federal Officer Last Name*de la Cruz
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixPhD, MPH
Specific Establishment Authority*42 U.S.C. 217aDesignated Federal Officer Phone*(301) 443-0543
Effective Date Of Authority*11/17/1962Designated Federal Officer Fax*(301) 594-0878
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*
Committee Type*Continuing
Committee Function*National Policy Issue Advisory Board


Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Committee met three times in Fiscal Year (FY) 2020, twice virtually via webinar, and once in person. The Committee is comprised of both voting members and non-voting ex-officio members.
How is membership balanced?*The Committee consists of the Assistant Secretary for Health; the Assistant Secretary for Children and Families; the Administrator for the Centers for Medicare and Medicaid Services; a senior representative from the Department of Education; the Director of the Centers for Disease Control and Prevention Division of Reproductive Health; a senior representative from the Department of Housing and Urban Development; a senior representative from the Department of Labor; the Director of the Agency for Healthcare Research and Quality’s Center for Primary Care, Prevention, and Clinical Partnerships; the Assistant Secretary for Food and Consumer Services, the United States Department of Agriculture; any appropriately qualified representative of the Department of Health and Human Services (HHS) or other agencies of the federal government designated by the Secretary of HHS as ex-officio members; and 21 members, including the Chair, selected by the Secretary. Members are representatives of both the public and private sectors. Members from the private sector represent corporations and foundations, the clergy, consumers, health and other professional organizations, health plans, and employers. Members from the public sector include elected officials and health and human services administrators from the state and local levels including representatives of minority, rural, and urban interests.
How frequent & relevant are cmte mtgs?*Meetings are typically held three times per FY. Committee meetings are necessary to generate new ideas to maintain progress on reducing infant deaths and disparities in infant mortality. This is addressed through the activities and efforts of a number of workgroups (that are formed on an ad hoc basis), and the discussion of new policies and scientific findings pertaining to maternal and infant health. In addition, the Committee continues to monitor and review the Healthy Start program and its evaluation, as well as Healthy People 2020 objectives. Work will continue to operationalize the national infant mortality reduction strategies.

ACIM advises the Secretary of the Department of Health and Human Services (HHS) on department activities and programs directed at reducing infant mortality and improving the health status of pregnant women and infants. The Committee provides guidance and focuses attention on the policies and resources required to address the reduction of infant mortality and the improvement of the health status of pregnant women and infants.

With a focus on life course, the Committee addresses disparities in maternal health to improve maternal health outcomes, including preventing and reducing maternal mortality and severe maternal morbidity. The Committee provides advice on how best to coordinate the myriad of federal, state, local, and private programs and efforts that are designed to deal with the health and social problems impacting infant mortality and maternal health.
Why advice can't be obtained elsewhere?*This Committee is necessary to provide the HHS with ongoing counsel and advice from a broad range of public and private sector expertise not available within HHS. The work of the Committee is especially important in light of the continued rise in preterm births, a major contributor to infant mortality, and an increased focus and attention on maternal health, maternal mortality, and severe maternal morbidity.
Why close or partially close meetings?N/A - ACIM meetings are open to the public.
Recommendation RemarksRecommendations have been shared with the Secretary and HRSA Administrator, and can be found in items 20a, and performance measures. No reports were issued for FY 2020. The Committee's Executive Secretary is the HRSA Associate Administrator for MCHB.

The FY21 estimated cost for Federal staff is expected to increase because the number of Committee meetings and the re-establishment of workgroups will require additional staff time and effort.

Michael Warren removed from the member list because he was converted to a federal employee at HRSA and has been in this position for all of FY 2020.


Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentNoAction Reallocate ResourcesYes
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentNA
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentThe Committee has been instrumental in providing guidance for the strengthening of the Healthy Start program, a major federal infant mortality reduction program; and advising about issues around or gaps in services, HHS programs, and research focused on preterm birth, infant mortality, and health disparities/health equity. More recently the Committee has worked to provide the Secretary with guidance and recommendations as the National Strategy to Address Infant Mortality is developed and operationalized.Number Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentNAGrants Review CommentNA
Number Of Recommendations*30Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentA major focus of the Committee is to assist the HHS Interagency Coordinating Council on Low Birth Weight and Preterm Birth develop recommendations for a Department-wide research agenda on low birth weight and preterm birth. Attention was given to establishing priorities for the research recommendations and to identify in a letter to the Secretary that this recommended research be initiated by HHS.
The Committee is also providing guidance and advice related to development and expansion of various MCHB programs. The Committee submitted a framework for the National Strategy to Address Infant Mortality. This framework has 6 key components/recommendations. The Committee continues to operationalize each of these components and will continue to submit specific action-oriented recommendations to the Secretary of HHS.
Access Agency WebsiteYes
% of Recs Fully Implemented*10.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThe 24 research priorities have been identified and were recently sent to the Secretary. One of the recommendations has been initiated (support the Institute of Medicine's study on preterm birth) through the joint efforts of several HHS agencies, including HRSA. Meanwhile the agency continues to address previous recommendations of the Committee that were not addressed in previous years. Pilot projects addressing systems delivery components contributing to variations in low birth weight continue to be funded.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*66.00%Access PublicationsYes
% of Recs Partially Implemented CommentMany recommendations presented by the committee have been partially implemented by the agency directly or in coordination with other agencies. For instance, the agency continues its work around maternal depression, funding projects in states as well as supporting the development of public education materials.Access OtherYes
Agency Feedback*YesAccess CommentBriefing books with meeting minutes and copies of presentations and relevant scientific materials are reproduced for Committee members and the public who attend each meeting. In addition, the agency shares summaries of subcommittee discussions by email with Committee members. HRSA also administers a website where relevant info is posted (
Agency Feedback Comment*The Committee Chair, HRSA Administrator, Executive Secretary of the Committee, and the Director of the Division that administers the Healthy Start program (or their designees) provide updates at committee meetings, specifically addressing progress on recommendations or questions raised. In addition, speakers from relevant HHS agencies and programs are invited to present on emerging issues and strategies to keep Committee members apprised of changes or advances (many of these federal partners also serve as ex-officios of the Committee). For instance, HHS officials described the strategies being considered for addressing the escalating costs in the Medicaid program, and CDC officials discussed ideas for improving attention to preconception care, an intervention being promoted to improve the outcome of pregnancy. Agency staff updated the Committee on the quality health improvement efforts in HRSA's Perinatal and Patient Safety collaborative. In addition, feedback is provided by other agencies and organizations (including outside of HHS) as appropriate (i.e., Institute of Medicine staff who reported findings from Federally-supported studies on Preterm Birth and Impact of Prenatal Weight).

As discussed below, in FY20 the HRSA Administrator also provided a response on behalf of the HHS Secretary to the two letters submitted by the Committee related to the effects of the COVID-19 pandemic on maternal and infant health.
Narrative Description*Infant mortality, and low birth weight (LBW)/preterm birth (PTB) as major contributors to infant death, continue to be significant and costly health problems for this Nation. It is alarming that the rates of LBW and PTB continue to increase.
Recommendations offered by the Committee with respect to content and coordination of programs to reduce infant mortality or improve the health of pregnant women and infants provide advice directly related to the HHS goals to: 1) improve quality of health services; 2) increase access for children; 3) eliminate health disparities; and 4) expand the knowledge base about underlying processes and factors associated with these health problems as well as interventions that will improve outcomes. With a lifecourse focus, the Committee also focuses on maternal health, maternal mortality, and severe maternal morbidity.

In FY20 the Committee focused on the COVID-19 pandemic and its effects on prenatal, labor and delivery, and newborn and infant care. The Committee sent two letters to the HHS Secretary and HRSA Administrator for the purpose of highlighting the importance of preventing infant and maternal deaths and severe morbidities, particularly as the healthcare systems became stressed due to the pandemic.

The HRSA Administrator responded on behalf of the Secretary to confirm the Department's continued commitment maternal and infant health, especially during the pandemic.

The two letters from the Committee and the Administrator's response are located on the Committee's website:
Hide Section - COSTS


Payments to Non-Federal Members*$13,500.00Est Payments to Non-Fed Members Next FY*$30,000.00
Payments to Federal Members*$94,213.00Est. Payments to Fed Members Next FY*$192,078.00
Payments to Federal Staff*$155,724.00Estimated Payments to Federal Staff*$159,390.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$7,439.00Est Travel Reimb Non-Fed Members nextFY*$34,000.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$129,909.00Est. Other Costs Next FY*$150,000.00
Total Costs$400,785.00Est. Total Next FY*$565,468.00
Federal Staff Support (FTE)*1.00Est. Fed Staff Support Next FY*1.00
Cost RemarksBecause of COVID-19 travel restrictions, two of the three meeting this year were virtual and therefore travel and per diem costs were minimized.
This year's Federal Staff costs include COR and additional Staff Member due to increased time spent to run and manage the activities of the Committee (including new member nomination package, 3 active workgroups, etc)
Est Cost RemarksWe anticipate that the Committee will have full membership by the second meeting of FY21. And, at this time, we are assuming for planning purposes that two of the three meetings will be in person. Therefore costs will be higher for travel and payment in FY21.
Hide Section - Interest Areas

Interest Areas

Basic Science
Basic Sciences
Small Business
Civil Rights
Civil Rights
Equal Opportunity
Native Americans
Computer Technology
Information Technology
Data Quality
Eligibility Programs
Social Services
Environmental Issues
Federal Employment
Public Services
Food and Drugs
Food and Drugs
Federal Government
State Government
Tribal Government
Health Care
Medical Education
Medical Practitioners
Nutrition for Women, Infants and Children
Physical Fitness
Public Health
Housing and Urban
Housing and Urban Development
Drug Abuse Policy and Enforcement
Juvenile Justice
Research and Statistics
Job Training
Workforce and Occupations
Health and Health Research
Medicine and Dentistry
Research and Statistics


To View all the members, meetings and advisory reports for this committee please click here


No Documents Found



Data from Previous Years

ActionCommittee System IDCommittee NameFiscal Year
 COM-036618Advisory Committee on Infant Mortality2019
 COM-034831Advisory Committee on Infant Mortality2018
 COM-001757Advisory Committee on Infant Mortality2017
 COM-002290Advisory Committee on Infant Mortality2016
 COM-004113Advisory Committee on Infant Mortality2015
 COM-004519Advisory Committee on Infant Mortality2014
 COM-005853Advisory Committee on Infant Mortality2013
 COM-006581Advisory Committee on Infant Mortality2012
 COM-008028Advisory Committee on Infant Mortality2011
 COM-008846Advisory Committee on Infant Mortality2010
 COM-010409Advisory Committee on Infant Mortality2009
 COM-010736Advisory Committee on Infant Mortality2008
 COM-012125Advisory Committee on Infant Mortality2007
 COM-012873Advisory Committee on Infant Mortality2006
 COM-014035Advisory Committee on Infant Mortality2005
 COM-014801Advisory Committee on Infant Mortality2004
 COM-015954Advisory Committee on Infant Mortality2003
 COM-016763Advisory Committee on Infant Mortality2002
 COM-017608Advisory Committee on Infant Mortality2001
 COM-018371Advisory Committee on Infant Mortality2000
 COM-019590Advisory Committee on Infant Mortality1999
 COM-020652Advisory Committee on Infant Mortality1998
 COM-021667Advisory Committee on Infant Mortality1997